Search PDMR transactions

Notifier
Name
Klaus Lykke Sindahl
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Klaus Lykke Sindahl
Position
Head of Investor Relations
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
Hansa Biopharma AB
LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Share Hansa Biopharma AB SE0002148817 Acquisition 568 Quantity 176.74 SEK 27/05/2019 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 27/05/2019 NASDAQ STOCKHOLM AB 568 (Quantity) 176.74 SEK
<< Back